Draft:Imtiaz A Chaudhry

Imtiaz A Chaudhry is a distinguished facial plastic surgeon and Opthalmologist with extensive expertise in cosmetic and reconstructive surgery of the eyelids, orbits, and facial region. A graduate of the University of Utah School of Medicine, he completed his residency in ophthalmology at Yale University and pursued a fellowship in ophthalmic plastic and reconstructive surgery at Baylor College of Medicine. With over two decades of experience, he has worked as the Chief of Oculoplastics and Orbital Surgery at King Khaled Eye Specialist Hospital[1] and currently serves as the Medical Director of Houston Oculoplastics. Dr. Chaudhry is affiliated with several prestigious Houston hospitals, including Houston Methodist and Baylor St. Luke’s Medical Center, and is an adjunct professor at the University of Texas-McGovern Medical School.

Renowned for his expertise, Dr. Chaudhry specializes in treating congenital and acquired defects, managing eyelid and orbital oncology, and performing advanced cosmetic procedures such as laser skin resurfacing and facial chemical peels. His contributions to the field, including over 200 published works and numerous international presentations, have earned him accolades such as the American Academy of Ophthalmology Achievement Award. Passionate about education, he has trained over 100 ophthalmology residents and 10 fellows[2], solidifying his status as a leader in ophthalmic plastic surgery and patient care.

Education

edit

Dr. Chaudhry completed his internship in internal medicine at Yale University School of Medicine, followed by his residency in Opthalmology at the Yale Eye Center, Yale University School of Medicine Department of Ophthalmology and Visual Sciences. He then went on to Baylor College of Medicine to complete his fellowship in Opthalmic Plastic and reconstructive surgery. He graduated from the University of Utah School of Medicine.

Publications and Presentations

edit

Outcome of Treated Orbital Cellulitis in a Teriary Eye Care Center in the Middle East[3]

L-Carnitine Protects Human Retinal Pigment Epithelial Cells from Oxidative Damage[4]

Epidemiology of giant cell arteritis in an Arab population: a 22-year study[5]

Common Eye Infections[6]

Trachoma and Conjunctivitis[7]

References

edit
  1. ^ "مستشفى الملك خالد للعيون".
  2. ^ "Imtiaz A. Chaudhry".
  3. ^ https://www.aaojournal.org/article/S0161-6420(06)01261-9/abstract
  4. ^ Shamsi, Farrukh A.; Chaudhry, Imtiaz A.; Boulton, Mike E.; Al-Rajhi, Ali A. (2007). "L-Carnitine Protects Human Retinal Pigment Epithelial Cells from Oxidative Damage". Current Eye Research. 32 (6): 575–584. doi:10.1080/02713680701363833. PMID 17612973.
  5. ^ Miller, N. R. (2007). "Epidemiology of giant cell arteritis in an Arab population: A 22-year study". The British Journal of Ophthalmology. 91 (6): 705–706. doi:10.1136/bjo.2007.114017. PMC 1955596. PMID 17510472.
  6. ^ Chaudhry, Imtiaz, ed. (2013). Common Eye Infections. doi:10.5772/45964. ISBN 978-953-51-0926-6.
  7. ^ A., Imtiaz; O., Yonca; Al-Rashe, Waleed (2011). "Trachoma and Conjunctivitis". Conjunctivitis - A Complex and Multifaceted Disorder. doi:10.5772/26435. ISBN 978-953-307-750-5.